Concepedia

Author

Kenza Daïri

Xenon Pharmaceuticals (Canada)

Also Known As

Kenza Dairi, Kenza Daïri

4

Publications

315

Citations

3

H-Index

10

Concepts

All Affiliations

Xenon Pharmaceuticals (Canada)
KD

About

Kenza Daïri is an author at Xenon Pharmaceuticals (Canada) specializing in drug development, natural sciences, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

30

2

Natural Sciences

1

1

30

3

Biochemistry

1

1

30

4

Biomolecular Engineering

1

1

30

5

Chemistry

1

1

67

Kenza Daïri

×

3

Publications

315

Citations

3

H-Index

YearCitations

The Small Molecule GMX1778 Is a Potent Inhibitor of NAD <sup>+</sup> Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

Mark H. Watson, Anne Roulston, Laurent Bélec,

Molecular and Cellular Biology

2009

218

Two-step synthesis of the bipyrrole precursor of prodigiosins

Kenza Daïri, Sasmita Tripathy, Giorgio Attardo,

Tetrahedron Letters

2006

67

A Scalable Process for the Synthesis of the Bcl Inhibitor Obatoclax

Kenza Daïri, Yuxing Yao, Michael Faley,

Organic Process Research & Development

2007

30

Page 1